Ruxolitinib salvage therapy is effective for steroid‐refractory graft‐versus‐host disease in children: A single‐center experience
Uygun, Vedat, Karasu, Gülsün, Daloğlu, Hayriye, Öztürkmen, Seda, Kılıç, Suar Çakı, Yalçın, Koray, Çelen, Safiye Suna, Hazar, Volkan, Yeşilipek, AkifLanguage:
english
Journal:
Pediatric Blood & Cancer
DOI:
10.1002/pbc.28190
Date:
January, 2020
File:
PDF, 274 KB
english, 2020